NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 140 filers reported holding NXSTAGE MEDICAL INC in Q4 2015. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $784,000 | +28.3% | 27,377 | +24.8% | 0.00% | – |
| Q3 2018 | $611,000 | -3.9% | 21,928 | -3.8% | 0.00% | – |
| Q2 2018 | $636,000 | -6.3% | 22,789 | -16.6% | 0.00% | -100.0% |
| Q1 2018 | $679,000 | -11.5% | 27,326 | -13.5% | 0.00% | 0.0% |
| Q4 2017 | $767,000 | -13.6% | 31,587 | -1.9% | 0.00% | 0.0% |
| Q3 2017 | $888,000 | +41.0% | 32,192 | +27.0% | 0.00% | 0.0% |
| Q2 2017 | $630,000 | -4.0% | 25,349 | +3.5% | 0.00% | 0.0% |
| Q1 2017 | $656,000 | +1.1% | 24,493 | -1.2% | 0.00% | 0.0% |
| Q4 2016 | $649,000 | +60.2% | 24,779 | +51.7% | 0.00% | – |
| Q3 2016 | $405,000 | +29.4% | 16,329 | +12.5% | 0.00% | – |
| Q2 2016 | $313,000 | +44.2% | 14,520 | 0.0% | 0.00% | – |
| Q1 2016 | $217,000 | -27.4% | 14,520 | +6.7% | 0.00% | – |
| Q4 2015 | $299,000 | +37.2% | 13,614 | 0.0% | 0.00% | – |
| Q3 2015 | $218,000 | +32.9% | 13,614 | +19.5% | 0.00% | – |
| Q2 2015 | $164,000 | -16.8% | 11,394 | 0.0% | 0.00% | – |
| Q1 2015 | $197,000 | +20.9% | 11,394 | +28.5% | 0.00% | – |
| Q4 2014 | $163,000 | +41.7% | 8,868 | 0.0% | 0.00% | – |
| Q3 2014 | $115,000 | – | 8,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 2,721,906 | $73,029,000 | 11.38% |
| DAFNA Capital Management LLC | 216,119 | $5,798,000 | 4.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,744,151 | $100,456,000 | 3.87% |
| KOPP INVESTMENT ADVISORS LLC | 117,779 | $3,160,000 | 3.09% |
| Perceptive Advisors | 1,818,189 | $48,782,000 | 2.78% |
| Pennant Capital Management, LLC | 1,927,408 | $51,712,000 | 2.45% |
| GILDER GAGNON HOWE & CO LLC | 4,955,630 | $132,960,000 | 2.24% |
| PURA VIDA INVESTMENTS, LLC | 275,000 | $7,378,000 | 2.18% |
| Portolan Capital Management | 545,032 | $14,623,000 | 1.90% |
| Tamarack Advisers, LP | 110,000 | $2,951,000 | 1.84% |